Clinical Trials Logo

Filter by:
NCT ID: NCT03352414 Terminated - Ileus Clinical Trials

Phase 2 RCT of Alvimopan vs. Placebo After CRS/HIPEC

ILEUS
Start date: March 8, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate the ability of alvimopan to reduce the time to return of bowel function in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Half of the participants will receive alvimopan or and half will receive placebo immediately before and for up to seven days after surgery.

NCT ID: NCT03351244 Terminated - Schizophrenia Clinical Trials

This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months

Start date: December 7, 2017
Phase: Phase 2
Study type: Interventional

The objective of the study is to investigate the efficacy, safety and tolerability of BI 409306 once daily compared with placebo given for 28 weeks in patients with schizophrenia on antipsychotic treatment. The study is designed to show superiority of BI 409306 over placebo in preventing relapse of schizophrenia symptoms.

NCT ID: NCT03351231 Terminated - Cancer Clinical Trials

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986242 Given in Combination With Nivolumab in Patients With Advanced Cancer

Start date: November 27, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to investigate safety of experimental medication BMS-986242 and Nivolumab in patients with advanced cancers.

NCT ID: NCT03350269 Terminated - Surgery Clinical Trials

Effect of Lost Wage Reimbursement to Kidney Donors on Living Donation Rates

Start date: November 15, 2017
Phase: N/A
Study type: Interventional

The study is designed as a randomized controlled trial. The investigators hypothesize that kidney transplant recipient candidates whose donors are offered reimbursement of lost wages (treatment arm) will have a higher probability of receiving a living donor kidney transplant than those randomized to no offer of lost wage reimbursement (control arm). The study expects to demonstrate incremental living donor kidney transplants by assisting individuals who wish to be living organ donors but would be otherwise unable to do so due to the obligatory forfeit of income during the evaluation, donation surgery, and post-operative recuperation periods.

NCT ID: NCT03349775 Terminated - Obesity Clinical Trials

Cardiometabolic Disease and Pulmonary Hypertension

Start date: November 27, 2017
Phase: Early Phase 1
Study type: Interventional

This study will investigate if metformin can help people with obesity and high pressures inside their lung blood vessels. Metformin is approved by the U.S. Food and Drug Administration (FDA) to treat diabetes, but metformin is not approved by the FDA to treat pulmonary hypertension. This study will examine whether Metformin will improve the high pressure inside lung blood vessels in people who are obese. The study will help understand the effect of metformin on pressures inside lung blood vessels.

NCT ID: NCT03349645 Terminated - Clinical trials for Severe Osteoarthritis of the Knee

Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the Knee

Start date: December 8, 2017
Phase: Phase 3
Study type: Interventional

This Open Label Extension (OLE) study will assess the safety of long-term treatment with a 4 mL intra-articular injection of Ampion™ in adults with pain due to severe osteoarthritis of the knee

NCT ID: NCT03349476 Terminated - Clinical trials for Paroxysmal Atrial Fibrillation

Model Based Fast Anatomical Mapping

MFAM
Start date: April 16, 2018
Phase: N/A
Study type: Interventional

This prospective, multicenter observational study will examine the ability of model based fast anatomical mapping (mFAM) to create left atrial (LA) geometry for atrial fibrillation ablation.

NCT ID: NCT03348904 Terminated - Lung Cancer Clinical Trials

Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer

Start date: December 27, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study was to evaluate the efficacy and safety of the combination of nivolumab plus epacadostat in combination with platinum chemotherapy compared with platinum chemotherapy alone, in participants with treatment-naïve Stage 4 or recurrent non-small cell lung cancer (NSCLC).

NCT ID: NCT03348163 Terminated - HIV Infections Clinical Trials

(mo)BETTA Trial in Transwomen for Optimization of ART

(mo)BETTA
Start date: June 6, 2018
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the safety and tolerability of a new HIV medication, bictegravir plus emtricitabine plus tenofovir alafenamide (B/FTC/TAF, 3 HIV medications combined into one pill) in HIV-infected transgender women (TW).

NCT ID: NCT03347253 Terminated - Clinical trials for Late-onset Pompe Disease

STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT

Start date: December 8, 2017
Phase:
Study type: Observational

The purpose of the study is to evaluate changes in key clinical outcome measures (eg, motor, respiratory, fatigue) in adult subjects with late-onset Pompe disease (LOPD) subjects receiving standard-of-care enzyme replacement therapy (ERT). Additionally, information gained may be used in the design and conduct of future studies in LOPD subjects.